Stockscreener 앱 받기
5.05
1.17%
-0.06
전일 마감가:
$5.11
열려 있는:
$5.01
하루 거래량:
110.17K
Relative Volume:
0.64
시가총액:
$59.48M
수익:
$442.00K
순이익/손실:
$-30.46M
주가수익비율:
-1.1323
EPS:
-4.46
순현금흐름:
$-27.47M
1주 성능:
-21.03%
1개월 성능:
-21.46%
6개월 성능:
+33.95%
1년 성능:
+3.27%
1일 변동 폭
$5.01
$5.40
1주일 범위
$4.50
$6.68
52주 변동 폭
$2.2801
$13.50
Clene Inc Stock (CLNN) Company Profile
명칭
Clene Inc
전화
801-676-9695
주소
6550 SOUTH MILLROCK DRIVE, SUITE G50, SALT LAKE CITY
CLNN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CLNN
Clene Inc
|
5.05 | 60.19M | 442.00K | -30.46M | -27.47M | -4.46 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Clene Inc Stock (CLNN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-10-04 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2022-07-18 | 개시 | H.C. Wainwright | Buy |
| 2022-05-02 | 개시 | Canaccord Genuity | Buy |
| 2021-09-28 | 개시 | Oppenheimer | Outperform |
Clene Inc 주식(CLNN)의 최신 뉴스
Nanotechnology Stocks Worth WatchingJanuary 17th - MarketBeat
Growth Value: Will PG E Corporation Preferred Security benefit from rising consumer demandSell Signal & Intraday High Probability Alerts - baoquankhu1.vn
Trading Action: Is Clene Inc exposed to currency risksEarnings Growth Report & High Conviction Investment Ideas - baoquankhu1.vn
Clene Inc. ten percent owner sells $292,184 in shares By Investing.com - Investing.com Nigeria
Shorts Report: Will CLNN stock recover after earningsMarket Movement Recap & Weekly Return Optimization Plans - baoquankhu1.vn
Aug Technicals: Is Clene Inc Equity Warrant stock a smart retirement pickWeekly Risk Summary & AI Powered Trade Plan Recommendations - baoquankhu1.vn
Best Nanotechnology Stocks Worth WatchingJanuary 16th - MarketBeat
Clene Inc. ten percent owner sells $292,184 in shares - Investing.com
Top Nanotechnology Stocks To Add to Your WatchlistJanuary 4th - MarketBeat
Clene to Present at the Emerging Growth Conference - The Manila Times
Best Nanotechnology Stocks To Follow TodayJanuary 15th - MarketBeat
Clene, FDA to discuss survival data and approval path for CNM-Au8 - ALS News Today
Winners Losers: Is Clene Inc a top pick in the sectorGap Up & Long-Term Growth Stock Strategies - baoquankhu1.vn
Risks Report: Is Clene Inc Equity Warrant stock positioned well for digital economyWeekly Profit Summary & AI Forecasted Entry/Exit Points - Bộ Nội Vụ
Clene (NASDAQ:CLNN) Director David Matlin Purchases 33,333 Shares of Stock - MarketBeat
Insider Buying: David Matlin Acquires Shares of Clene Inc (CLNN) - GuruFocus
Clene Announces Multi-Tranche Financing to Extend Cash Runway - TipRanks
Clene Signs Multiple Financing Agreements - TradingView — Track All Markets
Forecast Cut: Is Clene Inc. stock dividend yield sustainableQuarterly Profit Report & High Accuracy Investment Entry Signals - Bộ Nội Vụ
Promising Nanotechnology Stocks To Follow NowJanuary 13th - MarketBeat
FDA grants Clene in-person meeting to discuss ALS drug biomarker data - Investing.com Nigeria
Published on: 2026-01-13 07:04:12 - Улправда
Insider Selling: Clene (NASDAQ:CLNN) Major Shareholder Sells $19,457.55 in Stock - MarketBeat
Clene Inc. ten percent owner sells $256k in shares - Investing.com
Insider Selling: Clene (NASDAQ:CLNN) Major Shareholder Sells 32,705 Shares of Stock - MarketBeat
Clene (NASDAQ:CLNN) Major Shareholder Sells $56,900.25 in Stock - MarketBeat
Clene Inc. ten percent owner sells $256k in shares By Investing.com - Investing.com India
Clene Insider Sold Shares Worth $256,235, According to a Recent SEC Filing - marketscreener.com
Nanotechnology Stocks To ResearchJanuary 12th - MarketBeat
Clene (CLNN) Secures FDA Type C Meeting for ALS Treatment Review - GuruFocus
Clene Advances CNM-Au8 ALS Program with FDA Meeting - TipRanks
Clene announces additional Cnm-Au8 biomarker data supporting potential NDA filing for upcoming in-person FDA meeting - marketscreener.com
Clene Announces Additional CNM-Au8 Biomarker Data Supporting Potential NDA Filing for Upcoming In-Person FDA Meeting - The Manila Times
Clene Inc Announces Additional CNM-Au8 Biomarker Data for FDA Meeting - TradingView — Track All Markets
Promising Nanotechnology Stocks To Add to Your WatchlistJanuary 11th - MarketBeat
Top Nanotechnology Stocks To Follow TodayJanuary 8th - MarketBeat
Clene secures $28 million in registered direct offering for ALS drug - Investing.com Nigeria
Is Clene Inc. (84C0) stock a defensive play amid uncertainty2025 Volume Leaders & AI Powered Market Trend Analysis - Улправда
Chart Watch: Will Aterian Inc stock see PE expansionWatch List & Short-Term Trading Alerts - moha.gov.vn
Best Nanotechnology Stocks To Follow NowJanuary 9th - MarketBeat
Clene (CLNN) Secures $28 Million Through Direct Offering - GuruFocus
D. Boral Capital Maintains 'Buy' Rating for CLNN with $23 Target - GuruFocus
Clene announces registered direct offering of over $28 million - marketscreener.com
D. Boral Capital Reiterates Buy Rating for Clene (NASDAQ:CLNN) - MarketBeat
Clene secures $28 million in registered direct offering for ALS drug By Investing.com - Investing.com South Africa
Clene Inc. Announces Oversubscribed Registered Direct Offering Exceeding $28 Million to Fund ALS Treatment Development - Quiver Quantitative
Clene Announces Registered Direct Offering of Over $28 Million - marketscreener.com
Biotech Clene raises $28M ahead of potential FDA decision on ALS drug - Stock Titan
Can Clene Inc. Equity Warrant stock weather global recessionEarnings Recap Report & Growth-Oriented Investment Plans - Улправда
Will Clene Inc. Equity Warrant stock reach Wall Street targetsJobs Report & Free Long-Term Investment Growth Plans - Улправда
Chipmakers Recap: Is Clene Inc. (84C0) stock a top hedge fund pickMarket Weekly Review & Long Hold Capital Preservation Plans - Улправда
Clene Inc (CLNN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Clene Inc 주식 (CLNN) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Ugwumba Chidozie | 10% Owner |
Jan 14 '26 |
Sale |
5.12 |
19,621 |
100,460 |
662,861 |
| Ugwumba Chidozie | 10% Owner |
Jan 15 '26 |
Sale |
5.10 |
12,563 |
64,071 |
650,298 |
| MATLIN DAVID J | Director |
Jan 13 '26 |
Buy |
6.50 |
33,333 |
216,664 |
477,824 |
| Ugwumba Chidozie | 10% Owner |
Jan 12 '26 |
Sale |
5.50 |
32,705 |
179,878 |
708,587 |
| Ugwumba Chidozie | 10% Owner |
Jan 09 '26 |
Sale |
6.27 |
9,075 |
56,900 |
741,292 |
| Ugwumba Chidozie | 10% Owner |
Jan 08 '26 |
Sale |
6.09 |
3,195 |
19,458 |
750,367 |
| Ugwumba Chidozie | 10% Owner |
Jan 05 '26 |
Sale |
5.87 |
5,869 |
34,451 |
760,611 |
| Ugwumba Chidozie | 10% Owner |
Jan 07 '26 |
Sale |
6.29 |
3,938 |
24,770 |
753,562 |
| Ugwumba Chidozie | 10% Owner |
Jan 06 '26 |
Sale |
6.04 |
3,111 |
18,790 |
757,500 |
| Ugwumba Chidozie | 10% Owner |
Dec 31 '25 |
Sale |
5.81 |
13,095 |
76,082 |
770,495 |
4.73%
0.92%
자본화:
|
볼륨(24시간):